NeonMind Biosciences Inc. announced that it has appointed Dr. Gustavo Vazquez, MD, PhD, a Professor of Psychiatry at Queen's University in Kingston, Ontario, and a noted expert in mood disorders and ketamine utilization, to its Specialty Clinics Advisory Board. In his role on NeonMind's Specialty Clinics Advisory board, Dr. Vazquez will leverage his considerable expertise in organizing and managing ketamine clinics to support NeonMind as it develops its company-branded, specialty clinics network to increase patient access to evidence-backed effective treatments including ketamine. He was appointed Professor of Psychiatry at Queen’s University in 2016 and is currently working at the Mood Disorders Research and Treatment Service at Providence Care where he is the clinical lead of the Ketamine Clinic which has provided over 400 treatments since inception.